To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure email@example.com
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This book is the English translation of Gerald D. Feldman's contributions to the multi-author, two-volume study Österreichische Banken und Sparkassen im Nationalsozialismus und in der Nachkeriegszeit, which was originally published in German by C. H. Beck in 2006. Austrian Banks in the Period of National Socialism focuses on the activities of two major financial institutions, the Creditanstalt-Wiener Bankverein and the Länderbank Wien. It details the ways the two banks served the Nazi regime and how they used the opportunities presented by Nazi rule to expand their business activities. Particular attention is given to the role that the Creditanstalt and Länderbank played in the 'Aryanization' of Jewish-owned businesses. The book also examines the two banks' relations with their industrial clients and considers the question of whether bank officials had any knowledge of their client firms' use of concentration camp prisoners and other forced laborers during World War II.
Few controlled studies have examined the use of atypical antipsychotic drugs for prevention of relapse in patients with bipolar I disorder.
To evaluate whether olanzapine plus either lithium or valproate reduces the rate of relapse, compared with lithium or valproate alone.
Patients achieving syndromic remission after 6 weeks'treatment with olanzapine plus either lithium (0.6–1.2 mmol/l) or valproate (50–125 μg/ml) received lithium or valproate plus either olanzapine 5–20 mg/day (combination therapy) or placebo (monotherapy), and were followed in a double-masked trial for 18 months.
The treatment difference in time to relapse into either mania or depression was not significant for syndromic relapse (median time to relapse: combination therapy 94 days, monotherapy40.5 days; P=0.742), but was significant for symptomatic relapse (combination therapy 163 days, monotherapy42 days; P=0.023).
Patients taking olanzapine added to lithium or valproate experienced sustained symptomatic remission, but not syndromic remission, for longer than those receiving lithium or valproate monotherapy.